August 30, 2024 C-Path Announces FDA Commissioner Robert Califf to Participate in Opening Session at Inaugural Global Impact Conference C-Path is honored to announce that FDA Commissioner Robert M. Califf, M.D., MACC, will participate as a panelist...
August 22, 2024 C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research and Drug Development C-Path is thrilled to announce its CPLD Consortium has been awarded a grant from the Ara Parseghian...
August 22, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project in Prostate Cancer C-Path proudly announced today a $250,000 grant award to Peter Wipf, Ph.D...
August 20, 2024 C-Path Receives Data Transfer from The Champ Foundation Registry C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...
August 20, 2024 C-Path’s RDCA-DAP Announces Strategic Partnership with Vivli to Enhance Clinical Trials Data Sharing for Rare Diseases C-Path today announced a strategic data sharing partnership with Vivli, the nonprofit...
August 15, 2024 Clinical Outcome Assessments — Second Public Discussion Enjoy the recording and slides from this August 15 CP-RND webinar.
August 13, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project on Antibiotic-Resistant Gram-Negative Bacteria TUCSON, Ariz. August 13, 2024– Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
August 12, 2024 C-Path Welcomes CuraSen As Newest CPP Member C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.
August 8, 2024 C-Path’s TRxA Announces $250,000 Award for Drug Development Project in ALS TUCSON, Ariz., August 8, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced tod
C-Path Inaugural Global Impact Conference: Pioneering Drug Development Collaborations Sept. 9-11, 2024, Washington, D.C. TUCSON, Ariz., August 7, 2024 – Critical Path Institute (C-Path), whose mission is to lead co